Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray
Andrew HubermanKey Moments
Young blood factors may rejuvenate aging brain; organ aging varies; lifestyle matters.
Key Insights
Parabiosis experiments showed that old mice exposed to a young circulation can reactivate brain stem cells, reduce inflammation, increase neuronal activity, and improve memory.
Blood-borne factors aren’t just readouts of aging; they actively influence aging and organ function, offering potential therapeutic targets.
Early human work—plasma-derived fractions, therapeutic plasma exchange, and organ-age assays—suggests potential benefits but no FDA-approved rejuvenation therapy yet.
Aging is organ-specific; organ-age clocks built from blood proteomics reveal where aging runs fastest and help tailor interventions.
Exercise, fasting, sunlight, and hormones shape circulating factors; liver-derived signals appear to mediate brain benefits of exercise (e.g., clusterin, GLDH).
NAD precursors raise blood levels but lack demonstrated lifespan extension in humans; vitality gains may come with longevity tradeoffs.
INTRODUCTION TO YOUTHFUL BLOOD FACTORS
The discussion opens with the foundational idea that blood from a young organism can influence aging in an older one. In parabiosis experiments, old mice paired with young mice exhibited reactivated neural stem cells in the aging brain, reduced inflammation, and heightened neuronal activity, culminating in improved memory. This set the stage for viewing blood not merely as a nutrient-transport system but as a medium carrying factors that actively modulate aging. The question then becomes how to translate these findings to humans and identify the active components responsible for rejuvenation.
CANDIDATES AND MECHANISMS OF BLOOD-BORNE REJUVENATION
Researchers have since mapped a broad landscape of circulating molecules that differ between young and old blood. Some factors promote growth and tissue maintenance, while others drive inflammatory processes. Proteomic profiling across thousands of individuals reveals dramatic age-related shifts, suggesting that certain proteins may causally influence aging. Candidates discussed include growth factors such as GDF11 and IGF-1, which can support cellular activity, and more complex mediators such as clusterin (apolipoprotein J) and GLDH, linked to brain benefits observed after interventions like exercise. The field seeks a minimal, potent combination—essentially a rejuvenating cocktail—though consensus remains elusive.
TRANSLATING TO HUMANS: CLINICAL TRIALS AND PERSONALIZED BLOOD THERAPIES
To test concepts in humans, researchers helped launch ventures like Alkaist to assess whether young-blood factors influence aging phenotypes in mice and related human systems. Trials using plasma-derived fractions and components from healthy donors—along with therapeutic plasma exchange (where plasma is removed and replaced)—have yielded signals of benefit in neurodegenerative contexts like Alzheimer's and Parkinson's disease, but results are preliminary. Companies such as Circulate Therapeutics have conducted small, blinded studies with older adults, observing modest improvements in organ-age metrics, while Vero Biosciences pursues organ-specific aging predictions to guide interventions and monitor responses.
ORGAN-SPECIFIC AGING AND THE AGE GAP
A striking insight is that aging does not progress identically in all organs. Using broad proteomic readouts, researchers can estimate the 'age' of individual organs by looking at proteins originating from the brain, liver, heart, and other tissues present in blood. The concept of an organ-age gap—when an organ appears older or younger than the person’s overall age—predicts future disease risk for that organ. This has spurred the development of platforms like Vero Compass, which combine proteomic data, clinical metrics, and wearables to tailor interventions and repeatedly test organ-specific aging trajectories.
EXERCISE, SUNLIGHT, FASTING, AND HORMONES
A key theme is that vitality signals are not just intrinsic to tissues but are released systemically. Exercise, fasting, and even sunlight exposure appear to mobilize liver-derived factors that travel to the brain and other organs, enhancing function. Notably, clusters such as clusterin (ApoJ) and GLDH have been implicated as mediators of exercise benefits. The discussion also touches on puberty-era hormonal shifts and waves of aging in mid-life, highlighting that hormones and environmental factors can accelerate or modulate aging processes in complex, organ-specific ways.
THE BALANCE OF VITALITY AND LONGEVITY: TRADEOFFS AND FUTURE DIRECTIONS
The conversation circles back to a central tension: substances that boost vitality in youth, such as growth factors and hormones, may incur longevity costs later in life (antagonistic pleiotropy). Growth hormone/IGF-1 elevation can enhance energy, muscle, and cognition but often shortens lifespan in animal models, illustrating a vitality-longevity tradeoff. Possible interventions may require precision—targeting organ-specific aging and timing to maximize healthspan. While NAD precursors draw attention for their energetic effects, robust human evidence for lifespan extension is lacking. The takeaway is cautious optimism: lifestyle strategies plus targeted, well-validated therapies may extend healthspan without compromising longevity.
Mentioned in This Episode
●Supplements
●Tools & Products
●Books
●Studies Cited
●People Referenced
Common Questions
Parabiosis is a surgical model where an old and a young animal share circulation. In this setup, young blood factors can reactivate brain stem cells, reduce inflammation, increase neuronal activity, and, importantly, improve memory in old brains. These findings come from early rodent studies and have driven attempts to translate similar concepts to humans. Timestamp: 230
Topics
Mentioned in this video
Vitamin/mineral probiotic drink; sponsor product for health optimization.
Blood component referenced as the major plasma fraction used in therapeutic exchange experiments.
Researcher known for work on synapse formation and remodeling.
Company conducting blinded trials involving plasma-derived fractions for aging-related conditions.
Liver-derived factor implicated in brain resilience; recombinant clusterin mimics some exercise effects.
Gene-editing approach mentioned as a tool to knock out genes in vivo.
David protein bars (Bronze Bar); sponsor product high-protein, low-sugar snack.
David protein bars; sponsor product.
UPenn physician who pursued rapid, data-driven drug repurposing; discussed in context of unconventional cures.
Electrolyte drink containing sodium, magnesium, potassium; sponsor product.
Biomarkers used to estimate organ age from blood protein signals.
Cell-derived vesicles discussed as potential therapy/diagnostic tools; emerging field.
Growth factor described as a youthful component in young blood; discussed as a candidate.
Factor identified in exercise-related blood signaling with possible brain effects.
Company producing plasma products and facilitating clinical studies related to plasma-derived fractions.
Author of Spark; discussed in context of movement and brain plasticity.
Nicotinamide adenine dinucleotide; discussed with NMN as a longevity topic; debated for lifespan effects.
Nicotinamide mononucleotide; discussed as a supplement with contested longevity effects.
Nicotinamide riboside; discussed in the NAD-related longevity discussion.
Red-light filtering glasses to improve evening melatonin and sleep quality; sponsor product.
Graduate student who conducted parabiosis-related experiments and factor isolation.
Book on movement and brain plasticity by John Ratey.
Procedure to remove and replace plasma; discussed in context of aging and Alzheimer's trials.
Clinical procedure to remove plasma and infuse albumin; referenced in aging trials.
Colleague who used parabiosis to study aging of stem cells in muscle and prompted collaboration on brain aging.
Professor of neurology at Stanford; expert on factors in young blood and aging; discussed parabiosis and brain rejuvenation.
Company aiming to profile organ aging and predict responses to interventions using blood biomarkers.
Platform combining biological signatures with wearable data to tailor aging-interventions by organ.
More from Andrew Huberman
View all 17 summaries
31 minEssentials: The Biology of Taste Perception & Sugar Craving | Dr. Charles Zuker
189 minUnlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)
39 minUsing Light (Sunlight, Blue Light & Red Light) to Optimize Health | Huberman Lab Essentials
35 minEssentials: Optimize Your Exercise Program with Science-Based Tools | Jeff Cavaliere
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free